dana-farber cancer institute
Entity, reached from Hormuz.
- Evidence
- 32 documents · 16 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 31 Aug 2026, last seen 10 Oct 2026
- Measured
- 3% of mentions say something specific about it; the rest only name it
- As of
- 10 Oct 2026
Where this comes from
- The ASCO Post · 2026-09-22 · Metastatic HER2-Mutant NSCLC First-Line T-DXd (opens the source in a new tab)
- IPWatchdog · 2026-09-18 · Can the Patent System Keep Pace with Life Sciences Innovation? | IPWatchdog Unleashed (opens the source in a new tab)
- STAT News · 2026-09-05 · STAT+: Top Boston hospitals clash over Medicare Advantage network after split (opens the source in a new tab)
What is claimed about it
Situations it is named in
Who it moves with
- co-mentioned with lung cancer (15 documents)seen together
- co-mentioned with cancer center (13 documents)seen together
- co-mentioned with egfr (12 documents)seen together
- co-mentioned with iaslc (11 documents)seen together
- co-mentioned with wclc (11 documents)seen together
- co-mentioned with egfr-mutated (10 documents)seen together
- co-mentioned with her2 (10 documents)seen together
- co-mentioned with her2-directed (10 documents)seen together
- co-mentioned with her2-mutant (10 documents)seen together
- co-mentioned with t-dxd (9 documents)seen together